Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline in Restless Legs Syndrome (CATOR)
NCT00627003Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cabergoline in restless legs syndrome (RLS), sponsored by Pfizer. Started Nov 2002; status: completed.
02
Drugs
cabergoline
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00627003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627003.